Robier A Aguillon Prada MD
Critical Care Medicine, Nephrology
Associate Professor, Department of Pulmonary and Critical Care Medicine. McGovern School of Medicine, University of Texas, Houston
Join to View Full Profile
McGovern Medical School6431 Fannin StHouston, TX 77030
Dr. Aguillon Prada is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robier Aguillon Prada is an Intensivist and Nephrologist in Houston, TX and is affiliated with The University of Texas Houston McGovern Medical School. He practices at Memorial Hermann, Texas Medical Center.
He received his medical degree from Industrial University of Santander Faculty of Medicine and has been in practice 14 years. He trained at UCSD, The University of Miami, Duke University and Cleveland Clinic
Education & Training
Cleveland Clinic FoundationFellowship, Critical Care Medicine, 2013 - 2015
Duke University HospitalFellowship, Nephrology, 2011 - 2013
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
Industrial University of Santander Faculty of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2021 - 2026
OH State Medical License 2013 - 2023
NC State Medical License 2011 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 6 citationsExercise-induced alterations in phospholipid hydrolysis, airway surfactant, and eicosanoids and their role in airway hyperresponsiveness in asthma.Ryan C. Murphy, Ying Lai, James D. Nolin, Robier Aguillon Prada, Arindam Chakrabarti
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2021-02-03 - 47 citationsCanakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-1...Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, Robier Aguillon Prada, Tom Kai Ming Wang
Clinical Cardiology. 2020-08-24 - 3 citationsIntratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor RegressionMauricio Urquiza, Johanna Melo-Cardenas, R.A. Aguillon, Thomas J. Kipps, Januario E. Castro
Human Gene Therapy. 2015-01-01
Journal Articles
- Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, ...Paul C Cremer 1, Antonio Abbate 2, Kristin Hudock 3, Carla McWilliams 4, Jinesh Mehta 5, Steven Y Chang 6, Calvin C Sheng 1, Benjamin Van Tassell 2, Aldo Bonaventura 2..., Lancet Rheumatol . 2021 Jun;3(6):e410-e418, 3/17/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
